David E. Gerber, MD
Associate Professor of Internal Medicine and Clinical Sciences
Division of Hematology-Oncology
Associate Director for Clinical Research
Co-Leader, Experimental Therapeutics Program
Co-Director, Lung Disease Oriented Team
Harold C. Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, TX

David E. Gerber, MD is an Associate Professor of Internal Medicine and Clinical Sciences within the Hematology-Oncology Division at UT Southwestern Medical Center in Dallas, TX. He received his medical degree from Cornell University Medical College in New York, NY and completed a residency in Internal Medicine at UT Southwestern Medical Center in Dallas, TX. He completed a fellowship in medical oncology at Johns Hopkins University School of Medicine in Baltimore, MD and joined the UT Southwestern faculty in 2007.

Dr. Gerber’s research in lung cancer has generated over 80 peer-reviewed publications. He has also written two books and more than a dozen book chapters on the topic of lung cancer. He has received research grants from the American Cancer Society, the American Society of Clinical Oncology, the Cancer Prevention and Research Institute of Texas, the Department of Defense, and the National Cancer Institute.

Dr. Gerber serves as Associate Director for Clinical Research, Co-Leader of the Experimental Therapeutics Scientific Program, and Co-Director of the Lung Disease Oriented Team within the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern, Dallas, TX. He is an active member of the Eastern Cooperative Oncology Group Thoracic Committee. He also serves on the editorial board of the Journal of Clinical Oncology, as an Associate Scientific Advisor for Science Translational Medicine, and as a grant reviewer for the Department of Defense, the American Cancer Society, and the Conquer Cancer Foundation of the American Society of Clinical Oncology.